Are Concerns Over Avacopan Efficacy Overblown?
(MedPage Today) -- Avacopan (Tavneos), the complement pathway inhibitor for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), appeared strongly effective in an Italian registry study--a step, maybe, toward setting to rest...
Read more »